The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.
作者信息
LAWRENCE H S
出版信息
J Clin Invest. 1955 Feb;34(2):219-30. doi: 10.1172/JCI103075.
Abstract
摘要
相似文献
1
The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.
J Clin Invest. 1955 Feb;34(2):219-30. doi: 10.1172/JCI103075.
2
The transfer in humans of skin sensitivity of the tuberculin type with components of disrupted leukocytes.
Bull N Y Acad Med. 1956 Mar;32(3):236-8; discussion, 240-3.
3
Passive transfer of the delayed dermal sensitivity to tuberculin by means of blood leukocytes.
Am Rev Tuberc. 1958 Sep;78(3):346-52. doi: 10.1164/artpd.1958.78.3.346.
4
The influence of streptococcal toxin on the development of tuberculin sensitivity in guinea-pigs.
Br J Exp Pathol. 1954 Feb;35(1):85-91.
5
[Experimentally produced tuberculin cytolysis and tuberculin skin sensitivity].
Schweiz Med Wochenschr. 1957 Dec 21;87(51):1558-9.
6
Comparison between the degree of cutaneous tuberculin reactivity with the in vitro toxicity of tuberculin for peripheral blood leucocytes.
Tuberculol Thorac Dis. 1957 Mar;16(3):158-65.
7
[Variations in cutaneous sensitivity to tuberculin during insulin therapy].
Sem Hop. 1957 May 20;33(30):1937-40.
8
The in vitro effect of specific and nonspecific bacterial products on the migration of leukocytes from tuberculin-sensitized guinea pigs.
Am Rev Respir Dis. 1959 Jul;80(1, Part 1):19-25. doi: 10.1164/arrd.1959.80.1P1.19.
9
In search of nepenthe.
J Health Hum Behav. 1962;3:288-93.
10
Passive transfer of a delayed type of skin reactivity to tuberculin PPD.
Am Rev Respir Dis. 1959 Sep;80:398-403. doi: 10.1164/arrd.1959.80.3.398.
引用本文的文献
1
Feasibility Trial Exploring Immune-Related Biomarkers Pertaining to Rapid Immune Surveillance and Cytokine Changes after Consuming a Nutraceutical Supplement Containing Colostrum- and Egg-Based Low-Molecular-Weight Peptides.
Curr Issues Mol Biol. 2024 Jun 30;46(7):6710-6724. doi: 10.3390/cimb46070400.
2
Discovery of Transfer Factors in Plant-Derived Proteins and an In Vitro Assessment of Their Immunological Activities.
Molecules. 2023 Dec 5;28(24):7961. doi: 10.3390/molecules28247961.
3
Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future.
Vet Sci. 2021 Jun 11;8(6):109. doi: 10.3390/vetsci8060109.
4
Characterization and Safety Profile of Transfer Factors Peptides, a Nutritional Supplement for Immune System Regulation.
Biomolecules. 2021 Apr 29;11(5):665. doi: 10.3390/biom11050665.
5
Postulated Adjuvant Therapeutic Strategies for COVID-19.
J Pers Med. 2020 Aug 5;10(3):80. doi: 10.3390/jpm10030080.
6
Improvements of Motor Performances in the Loss-of-Function Model of Parkinson's Disease: Effects of Dialyzed Leucocyte Extracts from Human Serum.
Brain Sci. 2020 Jan 14;10(1):45. doi: 10.3390/brainsci10010045.
7
Histopathology of murine toxoplasmosis under treatment with dialyzable leukocyte extract.
Mem Inst Oswaldo Cruz. 2017 Nov;112(11):741-747. doi: 10.1590/0074-02760170045.
8
Physicochemical Characteristics of Transferon™ Batches.
Biomed Res Int. 2016;2016:7935181. doi: 10.1155/2016/7935181. Epub 2016 Jul 20.
9
CD8+ T cells produce a dialyzable antigen-specific activator of dendritic cells.
J Leukoc Biol. 2017 Jan;101(1):307-320. doi: 10.1189/jlb.3A0216-082R. Epub 2016 Aug 11.
10
Induction and treatment of anergy in murine leprosy.
Int J Exp Pathol. 2015 Feb;96(1):31-41. doi: 10.1111/iep.12108. Epub 2014 Dec 21.
本文引用的文献
1
THE ACTION OF STREPTOCOCCAL DESOXYRIBOSE NUCLEASE (STREPTODORNASE)IN VITRO AND ON PURULENT PLEURAL EXUDATIONS OF PATIENTS.
J Clin Invest. 1949 Sep;28(5 Pt 2):1094-104. doi: 10.1172/JCI102142.
2
Crystalline desoxyribonuclease; isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity.
J Gen Physiol. 1950 Mar;33(4):349-62. doi: 10.1085/jgp.33.4.349.
3
Quantitative cytochemical determination of desoxyribonucleic acid with the Feulgen nucleal reaction.
J Gen Physiol. 1949 Nov;33(2):125-46. doi: 10.1085/jgp.33.2.125.
4
Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus.
J Exp Med. 1952 Jul;96(1):71-82. doi: 10.1084/jem.96.1.71.
5
Transfer of penicillin resistance in pneumococci by the desoxyribonucleate derived from resistant cultures.
Cold Spring Harb Symp Quant Biol. 1951;16:457-61. doi: 10.1101/sqb.1951.016.01.032.
6
Immunochemical studies of antitoxin produced in normal and allergic individuals hyperimmunized with diphtheria toxoid. II. A comparison between the immunological properties of precipitating and non-precipitating (skin-sensitizing) antitoxins.
J Exp Med. 1952 Apr;95(4):375-92. doi: 10.1084/jem.95.4.375.
7
Immunochemical studies of antitoxin produced in normal and allergic individuals hyperimmunized with diphtheria toxoid. I. Relationship of skin sensitivity to purified diphtheria toxoid to the presence of circulating, non-precipitating antitoxin.
J Exp Med. 1952 Apr;95(4):363-74. doi: 10.1084/jem.95.4.363.
8
The cellular transfer in humans of delayed cutaneous reactivity to hemolytic streptococci.
J Immunol. 1952 Feb;68(2):159-78.
9
Cytological studies in association with local injections of streptokinase-streptodornase into patients.
J Clin Invest. 1950 Oct;29(10):1376-86. doi: 10.1172/JCI102375.
10
The intravenous injection of bovine crystalline pancreatic desoxyribonuclease into patients.
J Clin Invest. 1954 Dec;33(12):1670-86. doi: 10.1172/JCI103048.
Zotero 插件